EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Breast Cancer-Related Lymphedema

Bradford Sokol, Colby J. Hyland, Shailesh Agarwal, Justin Broyles, Faina Nakhlis, Erin M. Taylor

Lymphatics · 03.08.2026 · 4 (3) · 41

DOI: 10.3390/lymphatics4030041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lymphatics, online erschienen am 03.08.2026. Verfasst von Bradford Sokol und 5 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer-related lymphedema (BCRL) is a potentially debilitating outcome following breast cancer treatment. Much attention has been given to preventive and curative strategies for BCRL. Patients with inflammatory breast cancer (IBC) are at particularly increased risk, with approximately half of patients with IBC developing BCRL. We present preliminary outcome data for inflammatory breast cancer patients who undergo a multipronged preventative strategy with immediate lymphatic reconstruction at the time of axillary lymph node dissection, compressive arm sleeve wearing, and occupational therapy. We also present a literature review on IBC and BCRL.

Methods

A retrospective review of patients with IBC undergoing immediate lymphatic reconstruction with lymphovenous bypass at the time of axillary lymph node dissection was performed. All patients were referred to occupational therapy for establishment of care and arm sleeve fitting and had at least 12 months of follow-up. The primary outcome of interest was the development of lymphedema. Additionally, a narrative review of the literature was performed. All English language studies pertaining to BCRL in patients with IBC were considered.

Results

Eighteen patients with IBC underwent immediate lymphatic reconstruction with lymphovenous bypass between April 2022 and September 2023 by three reconstructive microsurgeons. Average follow-up time was 24.4 months (range 12.5–33.9 months). All patients underwent successful lymphovenous bypass of at least 1 channel. Of the 18 patients, 3 (16.6%) developed symptoms of lymphedema, such as heaviness of the posterior arm (2/3, 67%) or edema of the forearm (1/3, 33%). No patients developed >10% change in extremity volume.

Conclusions

BCRL is a debilitating and common outcome following breast surgery in patients with IBC. Immediate reconstruction with lymphovenous bypass coupled with occupational therapy and compression sleeve management may reduce the risk for BCRL in this population.

Zitieren

APA

Sokol, B., Hyland, C. J., Agarwal, S., Broyles, J., Nakhlis, F., & Taylor, E. M. (2026). Inflammatory Breast Cancer-Related Lymphedema. Lymphatics, 4(3), 41. https://doi.org/10.3390/lymphatics4030041

Vancouver

Sokol B, Hyland CJ, Agarwal S, Broyles J, Nakhlis F, Taylor EM. Inflammatory Breast Cancer-Related Lymphedema. Lymphatics. 2026;4(3):41. doi:10.3390/lymphatics4030041

BibTeX
@article{Sokol2026,
  author = {Sokol, Bradford and Hyland, Colby J. and Agarwal, Shailesh and Broyles, Justin and Nakhlis, Faina and Taylor, Erin M.},
  title = {Inflammatory Breast Cancer-Related Lymphedema},
  journal = {Lymphatics},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {41},
  doi = {10.3390/lymphatics4030041}
}
Kostenlos starten →